In lung cancer, T lymphocytes dominate the tumor microenvironment (TME), where CD4+ T cells coordinate immune responses via cytokine secretion, while CD8+ cytotoxic T lymphocytes (CTLs) eliminate neoplastic cells expressing tumor neoantigens (8). Here, CD4 is linked to lung carcinoma.